FDA Alert
FDA Alert
07/24/2023
Jessica Ganga
Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.
07/24/2023
FDA Alert
FDA Alert
07/21/2023
Jessica Ganga
The FDA has approved the first daily oral contraceptive for the prevention of pregnancy that does not require a health care provider’s prescription.
07/21/2023
FDA Alert
FDA Alert
07/21/2023
Jessica Ganga
The FDA has approved the first daily oral contraceptive for the prevention of pregnancy that does not require a health care provider’s prescription.
07/21/2023
FDA Alert
FDA Alert
07/21/2023
Jessica Ganga
The FDA has approved the first daily oral contraceptive for the prevention of pregnancy that does not require a health care provider’s prescription.
07/21/2023
FDA Alert
FDA Alert
07/19/2023
Jessica Ganga
Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.
07/19/2023
FDA Alert
FDA Alert
07/19/2023
Jessica Ganga
Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.
07/19/2023
FDA Alert
FDA Alert
07/19/2023
Jessica Ganga
Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.
07/19/2023
FDA Alert
FDA Alert
07/19/2023
Jessica Ganga
Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.
07/19/2023
FDA Alert
FDA Alert
06/15/2023
Jessica Ganga
The FDA approved the first treatment for pediatric patients who experience functional constipation
06/15/2023
FDA Alert
FDA Alert
06/15/2023
Jessica Ganga
The FDA approved the first treatment for pediatric patients who experience functional constipation
06/15/2023